The cost of health care for children and adults with sickle cell disease

被引:303
|
作者
Kauf, Teresa L. [1 ]
Coates, Thomas D. [2 ]
Liu Huazhi [1 ]
Mody-Patel, Nikita [3 ]
Hartzema, Abraham G. [1 ]
机构
[1] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL 32611 USA
[2] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Ctr Canc & Blood Dis, Los Angeles, CA 90033 USA
[3] Novartis Pharmaceut Inc, Hlth Econ & Outcomes Res, E Hanover, NJ USA
关键词
UNITED-STATES; MANAGED CARE; ANEMIA; HYDROXYUREA; PREVENTION; MORTALITY; ILLNESSES; MEDICAID; LIFE;
D O I
10.1002/ajh.21408
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although sickle cell disease (SCD) is marked by high utilization of medical resources, the full cost of care for patients with SCD, including care not directly related to SCD, is unknown. The purpose of this study was to estimate the total cost of medical care for a population of children and adults with SCD. We used data from individuals diagnosed with SCD enrolled in the Florida Medicaid program during 2001-2005 to estimate total, SCD-related, and non-SCD-related cost per patient-month based on patient age at the time of health care use. Across the 4,294 patient samples, total health care costs generally rose with age, from $892 to $2,562 per patient-month in the 0-9- and 50-64-year age groups, respectively. Average cost per patient-month was $1,389. Overall, 51.8% of care was directly related to SCD, the majority of which (80.5%) was associated with inpatient hospitalizations. Notably, non-SCD-related costs were substantially higher than those reported for the general US population. These results suggest a discounted (3% discount rate) lifetime cost of care averaging $460,151 per patient with SCD. Interventions designed to prevent SCD complications and avoid hospitalizations may reduce the significant economic burden of the disease. Am. J. Hematol. 84:323-327, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 50 条
  • [31] Care Seeking for Pain in Young Adults with Sickle Cell Disease
    Jenerette, Coretta M.
    Brewer, Cheryl A.
    Ataga, Kenneth I.
    PAIN MANAGEMENT NURSING, 2014, 15 (01) : 324 - 330
  • [32] Optimal disease management and health monitoring in adults with sickle cell disease
    Howard, Jo
    Thein, Swee Lay
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 505 - 512
  • [33] Rethinking Care Models for Young Adults With Sickle Cell Disease
    Boucher, Alexander A.
    Lyons, Margaret
    McGann, Patrick T.
    JAMA HEALTH FORUM, 2023, 4 (05):
  • [34] Advance Care Planning In Adults with Sickle Cell Disease (SCD)
    Bartholomew, Frederick
    De Castro, Laura M.
    BLOOD, 2010, 116 (21) : 175 - 176
  • [35] Fragmentation of Care for Young Adults with Sickle Cell Disease in California
    Shatola, Ashley
    Brunson, Ann M.
    Keegan, Theresa H. M.
    Wun, Ted
    Mahajan, Anjlee
    BLOOD, 2019, 134
  • [36] Palliative Care Teams as Advocates for Adults with Sickle Cell Disease
    Ajayi, Toluwalase A.
    Edmonds, Kyle P.
    Thornberry, Kathryn
    Atayee, Rabia A.
    JOURNAL OF PALLIATIVE MEDICINE, 2016, 19 (02) : 195 - 201
  • [37] Sickle Cell Disease in Adults: Developing an Appropriate Care Plan
    Matthie, Nadine
    Jenerette, Coretta
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (05) : 562 - +
  • [38] The Role of Oncology Nurses in the Care of Adults With Sickle Cell Disease
    Jenerette, Coretta
    Leak, Ashley
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2012, 16 (06) : 633 - 635
  • [39] Current treatment strategies for sickle cell disease in children and adults
    Schmugge, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 17 - 17
  • [40] Pain management for sickle cell disease in children and adults (Withdrawn)
    Dunlop, Robert
    Bennett, Kyle C. L. B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (04):